Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK ( TheStreet) -- This has truly become a treacherous market, Jim Cramer told his Mad Money viewers Friday. Fortunately, the week is over and Monday is a holiday for many.

That's why Cramer's game plan for next week's trading starts on Tuesday with earnings from JPMorgan Chase (JPM - Get Report) , Wells Fargo (WFC - Get Report) and Citigroup (C - Get Report) . Cramer said that each of these banks is different and investors will be looking for different things. Citigroup will provide a look into global growth, while Wells Fargo is measure of domestic growth. JPMorgan tends to thrive on volatility, so these past few weeks may be a good thing.

Also on Tuesday are Intel (INTC - Get Report) and CSX (CSX - Get Report) . Cramer said CSX will offer a another read on the U.S. economy, while Intel needs to post good numbers for the tech sector to avoid more selling.

Wednesday brings earnings from Netflix (NFLX - Get Report) , a cult stock that must blow away the numbers in order to take the high-multiple stocks higher.

Then, on Thursday, it's PPG (PPG - Get Report) offering up a read on the industrials including how things are faring in Europe.

Finally, on Friday, it's Honeywell (HON - Get Report) and General Electric (GE - Get Report) in the spotlight. Cramer said both companies may have a tough road ahead with Europe and energy slowing.

How Bad Are Europe and China?

Maybe, just maybe, politicians around the world are beginning to see the damage they've been causing. Those were Cramer's thoughts after hearing the news that leaders in China and Germany may be open to stimulating their economies to help get the world moving again.

This, after semiconductor maker Microchip Technologies (MCHP - Get Report) surprised investors by reporting that demand in China was weakening. Cramer said China is a huge buyer of semiconductors, so if things are bad for Microchip then things are pretty bad.

Things should have never gotten this bad, Cramer concluded. He said the world's leaders should have known that fears over Russia, ISIS, North Korea and Ebola were more than enough to warrant lower interest rates and more stimulus long ago.

Too Much Oil

Are the oil stocks sowing the seeds of their own demise? Cramer said the markets think so, and if things don't change the markets might be right.

Cramer said the production growth in the Permian Basin in Texas has been staggering, and the region now produces 1.7 million barrels of oil a day. But that number is expected to double in just two to three years' time and only adds to the production growth in the Bakken, Eagle Ford, Marcellus and other shale fields around our nation.

But the problem remains there simply isn't enough storage or refining capacity to use all our new-found oil and the U.S. still has no energy policy, no leadership and exporting oil remains illegal.

That's why oil prices are plummeting, said Cramer, and why the oil stocks are following suit. America could indeed be energy self-sufficient in just three years, but that just won't happen if oil prices fall into the $70s.

More important, if oil prices continue to decline, America will begin to lose jobs in the only states that have thus far been unaffected by the global slowdown. Increasing unemployment in these oil-rich states could be a major factor for the U.S. economy.

Executive Decision: Stanley Crooke

For his "Executive Decision" segment, Cramer spoke with Dr. Stanley Crooke, chairman and CEO of Isis Pharmaceuticals (ISIS) , a stock that's nearly quadrupled since Cramer first recommended it two years ago, but also one that's 22 points off its highs for the year.

Crooke commented on today's news that its orphan drug to treat infant spinal muscular atrophy, currently in Phase II testing, has seen remarkable results. He said the drug, IsisSMN, has proven to not only prolong life for infants that typically die in their first two years, but has also improved muscular development.

Crooke continued there are currently no other treatment options available for the 30,000 to 40,000 infants a year afflicted with this rare condition, and both Isis and the FDA are working to complete Phase III testing as quickly as possible.

Cramer said Isis remains a terrific story. Once the global morass subsides, this will be among the stocks heading significantly higher.

Lightning Round

In the Lightning Round, Cramer was bullish on Procter & Gamble (PG - Get Report) , Kimberly-Clark (KMB - Get Report) and Mallinckrodt (MNK - Get Report) .

Cramer was bearish on Organovo Holdings (ONVO - Get Report) , FMC Corp (FMC - Get Report) and Expedia (EXPE - Get Report) .

Off The Tape

In his "Off The Tape" segment, Cramer sat down with John Ballay, co-founder and president of the privately held Knot Standard, a startup hoping to take the process of buying tailored men's clothing out of the store and into the online era.

Ballay explained that Knot Standard sells its men's wear online and through corporations but also through seven showrooms around the globe. The showrooms, he noted, were created out of necessity because buyers aren't quite comfortable with an online-only platform just yet.

Knot Standard features over 1,000 fabric options as well as a "match your suit" program where customers can simply provide the company with an existing suit and they'll replicate it perfectly. Suits from Knot Standard sell for up to a third off retail thanks to its direct-to-consumer model.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

-- Written by Scott Rutt in Washington, D.C.

To email Scott about this article, click here: Scott Rutt

Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC

At the time of publication, Cramer's Action Alerts PLUS had no position in stocks mentioned.